SUMMARY Serum antibodies cytotoxic to the colon cancer cell line RPMI 4788 were studied in 42 patients with ulcerative colitis, 61 patients with Crohn's disease, 27 patients with other inflammatory diseases (disease-controls) and 22 healthy controls. Cytotoxicity of antibodies towards RPMI 4788 was studied by means ofa chromium release assay using peripheral blood mononuclear leucocytes of healthy subjects as effector cells. Using a four hour antibody dependent cell mediated cytotoxicity assay sera from 29% of ulcerative colitis patients contained antibodies cytotoxic for the target, while only 3% of the Crohn's patients and 6% of the disease controls and non of the healthy controls were positive. When an 18 hour assay was applied, however, not only 40% of ulcerative colitis patients,' but also 14% of Crohn's patients and 21% of disease controls were found positive. The reactive antibody in the four hour assay was mainly of the IgG class, which points at a classical antibody dependent cell mediated cytotoxicity mechanism. In the 18 hour cytotoxic assay IgG and particularly IgM antibodies were found to be reactive. This suggests that in the latter case other cellular cytotoxic mechanism might be involved. There was a significant inverse correlation between the appearance of the ulcerative colitis restricted IgG-anticolon epithelial cell antibodies (four hour assay) and the disease activity (p<001). Absorption studies showed that the reactive antigen is not specific for ulcerative colitis colonic tissue, but is similarly found in Crohn's bowel tissue, and to a lower extent in normal bowel, liver and kidney. The reactive antigen, however, could not be detected in brain and lymphoblastoid cells.
IBD patients
The diagnosis of UC or CD was confirmed histologically in all of the 42 UC patients and the 61 CD patients. In UC disease activity (UCAI) was arbitrarily scored using the Crohn's disease activity index'2 with the following modifications: In variable X 4 of the CDAI, the symptoms of anal fissure, abscess or fistula were replaced by 'blood in the faeces'. In variable X 6, sedimentation rate of 30 mm in the first hour was used instead of 'abdominal mass'. Eleven of the UC patients had proctosigmoiditis, nine suffered from left sided colitis and 16 from universal colitis. In the CD patients, the disease was restricted to the ileum in 16 cases, to the small bowel as well as the colon in 33 cases and the colon in seven cases.
Controls
Twenty seven patients with inflammatory diseases other than IBD were also tested. This group of disease controls (group D) consisted of six patients with systemic lupus erythematosus (SLE), five patients with rheumatoid arthritis (RA) or ankylosing spondylitis, five patients with inflammatory bowel diseases other than IBD (diverticulitis, salmonellosis, shigellosis), four patients with renal disease, two patients with cirrhosis of the liver and one patient, each with irritable bowel disease, cholangitis, lymphosarcoma, AIDS, and dermatomyositis. In addition, sera of 22 healthy controls (group N) were tested.
SERUM SAMPLES
Serum samples were obtained by venous puncture. Blood was centrifuged within 30 minutes after bleeding. Sera were stored at -80°C in small aliquots. LEUCOCYTE 
SEPARATION
In all assays peripheral blood mononuclear leucocytes (PBML) obtained by Ficoll Isopaque density gradient centrifugation were used. Peripheral blood mononuclear leucocytes were resuspended to a concentration of 5 x 106 cells/ml in culture medium (CM) consisting of RPMI 1640 (GIBCO, Grand Island, NY) plus HEPES (25 mM) supplemented with penicillin (10 U/ml), streptomycin (100 ,tg/ml), gentamycin (50 [sg/ml), fungizone (0.25 psg/ml), L- In very few instances 11Cr release values of the serum controls were higher than that of spontaneous release, which indicated unspecific cytotoxicity. Therefore, the results of such sera were discarded.
SEPARATION OF THE IMMUNOGLOBULIN CLASSES G, M, AND A
The sera were chromatographically separated by application of the FPLC system (Pharmacia, Sweden). The major three immunoglobulin classes were fractioned from 1-2 ml serum by Mono Q column as an anion exchanger.'5 The fractionation was achieved by a step gradient of phosphate buffer (0.025 M, pH 6-7-0-3 M, pH 6-5, total volume 40 ml). IgG-enriched fractions contained 60 to 65% IgG of the total protein. These fractions were depleted of IgM (<0-008 g/l) as well as IgA (<0-008 g/dl). IgM enriched fractions contained 5 to 10% IgM of the total protein and were free of IgG (<0-008 g/l) and IgA (<0-011 g/l); IgA enriched fractions contained 5 to 10% IgA of the total protein and were free of IgG (<0-011 g/l) and IgM (<0-008 g/l).
Using the Millipore ultrafiltration units (Millipore, Mass, USA) the Ig-fractions were concentrated to an extent that the concentration of the enriched Ig was comparable to the concentration of the corresponding immunoglobulin in the original serum, unless otherwise stated.
ABSORPTION STUDIES
The absorption of sera with human tissue, colon cancer cells and lymphoblastoid cells was done according to Nagai and Das" with minor modifications. Tissues of colon and ileum from UC-, CD-, and colon cancer patients (in the latter case only uninvolved areas of the tissue were used) were obtained from fresh surgical specimens, while liver, kidney and brain tissue were obtained from autopsy specimens.
Mucosal bowel tissue was separated from serosa and muscle layer. Mucosa or the tissues of other organs were minced into pieces and homogenised eight times for 10 seconds on ice by Ultra Turrax (OKA Staufen, RFG). These homogenates were mixed with an equal volume of cold 0.01 M PBS (v/w) containing 2 mM phenylmethylsulfonylfluoride (PMSF) as protease inhibitor and were washed three times. The pellet obtained by the last centrifugation at 1250 g for 4°C was mixed with an equal volume of serum and incubated at 4°C under permanent shaking for one hour. Absorbed sera were recovered from the homogenates by centrifugation at 1250 g for 30 minutes at 4°C.
In the same manner sera were absorbed with colon cancer cells (RPMI 4788) (Fig. la) . None of the normal controls showed any cytotoxicity. In contrast, when incubation was done for 18 hours, not only 40% of UC, but also 14% of CD-patients and 21% of D patients were positive, while normals remained negative throughout (Fig.  lb) .
In the four hour assay HeLa cells were lysed by only two of 21 UC sera (7%), none out of 20 CD sera and three of 10 normal sera. Five of these 21 UC sera lysed the RPMI 4788 target. Only one of these five sera was cytotoxic also towards the HeLa target, while the second UC serum cytotoxic against HeLa cells did not lyse RPMI 4788 cells. Figure 2 illustrates the results obtained by serum fractions from high titre UC-sera which have been enriched for one of the three main Ig-fractions and depleted of the other two by means of FPLC (see methods).
IMMUNOGLOBULIN CLASSES OF CYTOTOXIC ANTIBODIES
In the four hour assay ( Fig. 2 ; UCI, UC2) cytotoxicity was primarily exerted by the IgG fraction when used in the same Ig-concentration as that in the original serum. IgM poorly, and IgA never mediated any cytotoxicity in the four hour assay. When highly enriched immunoglobulin concentrations were applied (three to four-fold higher concentrated than in the original serum) not only the IgG-mediated cytolysis increased significantly, but also some IgMdependent cytotoxicity could be observed in the four hour assay ( Fig. 2; UC2b, UC3, CD) . In the 18 hour assay, however, cytolysis was mainly mediated by the IgM fractions. Time kinetics of the concentrated Igfractions made obvious that the IgM-dependent cytolysis increased considerably during the 14 hour incubation period following the first four hours incubation (UC2b, UC3, CD), while the IgG. fractions had reached their peak cytotoxicity already after four hours and did not increase further. The IgG-mediated cytotoxicity rather became even lower in some instances with ongoing incubation (UC3). This latter effect is caused by the time dependent rise of the SCMC (UC2, UC3, UC4), which had always to be subtracted from the total cytotoxicity to obtain the antibody dependent cell mediated cytotoxicity. Figure 3 shows, however, one absorption step with bowel tissue from CD patients colon as well as ileum, also abolished the cytotoxic activity of the sera. Absorption with normal ileal and colonic tissue from colon cancer patients (Fig. 3) or with RPMI 4788 (Fig. 4) had a consistent absorbing effect on the cytotoxic activity in the four hour assay, while these tissues hardly showed an absorbing effect in the 18 hour assay (not shown). Under these latter experimental conditions, one absorption step with RPMI 4788 hardly removed cytotoxic activity, which was abolished after repeated absorption with these cells. Also absorption with kidney and liver considerably decreased the cytotoxic activity in both assays, while one absorption step with brain or with the lymphoblastoid LIK-line had virtually no effect on the cytotoxic activity (Fig. 4) . Even with repeated absorption these latter tissues did not alter the cytotoxic activity towards RPMI 4788.
Discussion
This study showed that specifically in UC sera of about one third of patients contain antibodies which direct a cell mediated cytotoxicity against the human colon cancer cell line RPMI 4788 in a four hour assay and that mainly IgG-antibodies mediate this UC specific cytotoxicity. Sera of patients with CD, other inflammatory diseases or normal controls barely exerted such an activity. HeLa-cells, which were used as control target, were not lysed by 'positive' UC-sera (cytotoxic to RPMI 4788) with one exception, as vice versa most sera cytotoxic towards HeLa did not exert lytic activity against RPMI 4788. Similar results have been reported by Nagai and Das."
As second important finding, which has not been reported so far, we observed a similar cytotoxicity of UC-sera against the cell line RPMI 4788 in an 18 hour assay. This 18 hour cytotoxicity has, however, also been found in patients with CD and in patients with inflammatory diseases other than IBD. Thus, it was o 1-x\X .i.. rl X .. ..1 r.a . -.v-not as strongly restricted to UC as the four hour cytotoxicity. In contrast with the four hour cytotoxicity, which was primarily mediated by IgG, the 18 hour cytotoxicity assay was mainly conferred by IgM.
Thus, the cytotoxic antibodies towards colonic epithelial cells detected in the four hour and 18 hour assay do not only show a different prevalence in the various disease groups, but in addition, they belong to different immunoglobulin classes. Although ADCC might also be mediated through IgAantibodies,'6 we could not observe any cytotoxicity in the IgA enriched and the IgG as well as IgM depleted serum fractions. Nagai and Das have also found the cytotoxicity against RPMI 4788 in the IgG class of the UC serum." These authors, however, did not evaluate other Ig fractions.
It is unclear at present, whether the restriction of cytotoxic IgG-anticolonic epithelial cell antibodies detected in the four hour assay to UC might be the result of an UC restricted immunological capability to switch from IgM to IgG production of these cytotoxic antibody, or, whether this might have to do with the observation, that in UC-sera the IgG 1-subtype predominates.`' IgG 1 is particularly apt to mediate ADCC.
Unlike a previous report of a positive correlation between the appearance of UC restricted cytotoxic IgG serum anticolon antibodies and disease activity in UC'8 we observed an inverse correlation. This discrepancy of the findings might be in part caused by differences in assessing the disease activity of patients with UC. The ulcerative colitis activity index (UCAI) used in the present study, however, has been successfully applied in elaborating the influence of disease activity both on ConA-generated, irradiated Tsuppressor cells to suppress the proliferation of autologous lymphocytes, stimulated by PHA, PWM or mixed lymphocyte culture and on the spontaneous T-suppressor cell activity to suppress PHA and ConA stimulated lymphocyte proliferation. ' Whether this inverse correlation between disease activity and the appearance of circulating cytotoxic IgG-anticolon antibodies might be the result of the binding of the antibody to bowel tissue during active disease remains speculative at present.
As a fourth finding, our extensive absorption studies revealed that the reactive antigen(s) of the UC-restricted cytotoxic IgG-anticolon-epithelial antibody is present both in UC colon and in ileal as well as colonic tissue of patients with CD, and even in normal liver, kidney, ileum and -although to a lower extent -colon. This contrasts with the previous report of Nagai and 
